Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25

Neuropeptides

Volumn 42, Issue 5-6, 2008, Pages 611-621

  Héraud, Céline ^a   Chevrier, Lucie ^a   Meunier, Annie Claire ^a   Muller, Jean Marc ^a   Chadéneau, Corinne ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Differentiation; Neuritogenesis; Neuroblastoma; SNAP 25 mRNA isoforms; VIP

Indexed keywords

SYNAPTOSOMAL ASSOCIATED PROTEIN 25; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NERVE GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEURITE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; NEURITES; NEUROBLASTOMA; PROTEIN ISOFORMS; RNA INTERFERENCE; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; VASOACTIVE INTESTINAL PEPTIDE;

EID: 56649114459     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.05.005     Document Type: Article

References (66)

1. Andersson J., Fried G., Lilja L., Meister B., and Bark C. Differential sorting of SNAP-25a and SNAP-25b proteins in neuroblastoma cells. Eur. J. Cell. Biol. 79 (2000) 781-789
2. Apland J.P., Adler M., and Oyler G.A. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25. J. Protein Chem. 22 (2003) 147-153
3. Arias E., Gallego-Sandín S., Villarroya M., García A.G., and López M.G. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J. Pharmacol. Exp. Ther. 315 (2005) 1346-1353
4. Bark I.C. Structure of the chicken gene for SNAP-25 reveals duplicated exon encoding distinct isoforms of the protein. J. Mol. Biol. 233 (1993) 67-76
5. Bark I.C., and Wilson M.C. Human cDNA clones encoding two different isoforms of the nerve terminal protein SNAP-25. Gene 139 (1994) 291-292
6. Bark I.C., Hahn K.M., Ryabinin A.E., and Wilson M.C. Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development. Proc. Natl. Acad. Sci. USA 92 (1995) 1510-1514
7. Bark C., Bellinger F.P., Kaushal A., Mathews J.R., Partridge L.D., and Wilson M.C. Developmentally regulated switch in alternatively spliced SNAP-25 isoforms alters facilitation of synaptic transmission. J. Neurosci. 24 (2004) 8796-8805
8. Blondel O., Collin C., McCarran W.J., Zhu S., Zamostiano R., Gozes I., Brenneman D.E., and McKay R.D. A glia-derived signal regulating neuronal differentiation. J. Neurosci. 20 (2000) 8012-8020
9. Boschert U., O'Shaughnessy C., Dickinson R., Tessari M., Bendotti C., Catsicas S., and Pich E.M. Developmental and plasticity-related differential expression of two SNAP-25 isoforms in the rat brain. J. Comp. Neurol. 367 (1996) 177-193
10. Cai F., Chen B., Zhou W., Zis O., Liu S., Holt R.A., Honer W.G., and Song W. SP1 regulates a human SNAP-25 gene expression. J. Neurochem. 105 (2008) 512-523
11. Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., Parks J.P., Parker Jr. W.D., and Bennett Jr. J.P. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362 (1997) 77-86
12. Catsicas S., Larhammar D., Blomqvist A., Sanna P.P., Milner R.J., and Wilson M.C. Expression of a conserved cell-type-specific protein in nerve terminals coincides with synaptogenesis. Proc. Natl. Acad. Sci. USA 88 (1991) 785-789
13. Chauhan N.B., and Siegel G.J. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody. J. Neurosci. Res. 69 (2002) 10-23
14. Choi I., Cho B.R., Kim D., Miyagawa S., Kubo T., Kim J.Y., Park C.G., Hwang W.S., Lee J.S., and Ahn C. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing. J. Biotechnol. 120 (2005) 251-261
15. Constantinescu R., Constantinescu A.T., Reichmann H., and Janetzky B. Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. J. Neural. Transm. Suppl. 72 (2007) 17-28
16. Delgado M., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J. Biol. Chem. 276 (2001) 369-380
17. Delgado-Martínez I., Nehring R.B., and Sørensen J.B. Differential abilities of SNAP-25 homologs to support neuronal function. J. Neurosci. 27 (2007) 9380-9391
18. Downes E.C., Robson J., Grailly E., Abdel-All Z., Xuereb J., Brayne C., Holland A., Honer W.G., and Mukaetova-Ladinska E.B. Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals. Neuropathol. Appl. Neurobiol. 34 (2008) 12-22
19. Drahushuk K., Connell T.D., and Higgins D. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons. J. Neurosci. 22 (2002) 6560-6569
20. Fatemi S.H., Earle J.A., Stary J.M., Lee S., and Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 12 (2001) 3257-3262
21. Fernandez M., Sanchez-Franco F., Palacios N., Sanchez I., and Cacicedo L. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1. J. Mol. Endocrinol. 34 (2005) 699-712
22. Ferrer I. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease. Cerebellum 1 (2002) 213-222
23. Garcia-Palomero E., Montiel C., Herrero C.J., Garcia A.G., Alvarez R.M., Arnalich F.M., Renart J., Lara H., and Cardenas A.M. Multiple calcium pathways induce the expression of SNAP-25 protein in chromaffin cells. J. Neurochem. 74 (2000) 1049-1058
24. Glass T.L., Raabe T.D., Garcia D.M., and Koke J.R. Phosphorylated neurofilaments and SNAP-25 in cultured SH-SY5Y neuroblastoma cells. Brain Res. 934 (2002) 43-48
25. Greber S., Lubec G., Cairns N., and Fountoulakis M. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis 20 (1999) 928-934
26. Grosse G., Grosse J., Tapp R., Kuchinke J., Gorsleben M., Fetter I., Höhne-Zell B., Gratzl M., and Bergmann M. SNAP-25 requirement for dendritic growth of hippocampal neurons. J. Neurosci. Res. 56 (1999) 539-546
27. Hepp R., and Langley K. SNAREs during development. Cell Tissue Res. 305 (2001) 247-253
28. Hepp R., Dupont J.L., Aunis D., Langley K., and Grant N.J. NGF enhances depolarization effects on SNAP-25 expression: induction of SNAP-25b isoform. Neuroreport 12 (2001) 673-677
29. Hepp R., Grant N.J., Chasserot-Golaz S., Aunis D., and Langley K. The hypophysis controls expression of SNAP-25 and other SNAREs in the adrenal gland. J. Neurocytol. 30 (2001) 789-800
30. Héraud C., Hilairet S., Muller J.M., Leterrier J.F., and Chadéneau C. Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5Y cells is associated with regulated expression of cytoskeleton mRNAs and proteins. J. Neurosci. Res. 75 (2004) 320-329
31. Hokari R., Lee H., Crawley S.C., Yang S.C., Gum Jr. J.R., Miura S., and Kim Y.S. Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G949-G959
32. Imamura K., Takeshima T., Kashiwaya Y., Nakaso K., and Nakashima K. d-β-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J. Neurosci. Res. 84 (2006) 1376-1384
33. Jahn R., Lang T., and Sudhof T.C. Membrane fusion. Cell 112 (2003) 519-533
34. Jämsä A., Hasslund K., Cowburn R.F., Bäckström A., and Vasänge M. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation. Biochem. Biophys. Res. Commun. 319 (2004) 993-1000
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
36. Lam P.M., Hainsworth A.H., Smith G.D., Owen D.E., Davies J., and Lambert D.G. Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell death. J. Neurochem. 102 (2007) 801-811
37. Latchman D.S. The Brn-3a transcription factor. Int. J. Biochem. Cell. Biol. 30 (1998) 1153-1157
38. Lee S.Y., Andoh T., Murphy D.L., and Chiueh C.C. 17β-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection. FASEB J. 17 (2003) 947-948
39. Li Z., Van Aelst L., and Cline H.T. Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo. Nat. Neurosci. 3 (2000) 217-225
40. Mayer C., Popanda O., Zelezny O., von Brevern M.C., Bach A., Bartsch H., and Schmezer P. DNA repair capacity after gamma-irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes. DNA Repair (Amst.) 1 (2002) 237-250
41. Monaghan T.K., Mackenzie C.J., Plevin R., and Lutz E.M. PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. J. Neurochem. 104 (2008) 74-88
42. Montiel C., Mendoza I., Garcia C.J., Awad Y., Garcia-Olivares J., Solis-Garrido L.M., Lara H., Garcia A.G., and Cardenas A.M. Distinct protein kinases regulate SNAP-25 expression in chromaffin cells. J. Neurosci. Res. 71 (2003) 353-364
43. Morihara T., Mizoguchi A., Takahashi M., Kozaki S., Tsujihara T., Kawano S., Shirasu M., Ohmukai T., Kitada M., Kimura K., Okajima S., Tamai K., Hirasawa Y., and Ide C. Distribution of synaptosomal-associated protein 25 in nerve growth cones and reduction of neurite outgrowth by botulinum neurotoxin A without altering growth cone morphology in dorsal root ganglion neurons and PC-12 cells. Neuroscience 91 (1999) 695-706
44. Mukaetova-Ladinska E.B., Hurt J., Honer W.G., Harrington C.R., and Wischik C.M. Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci. Lett. 317 (2002) 161-165
45. Muller J.M., Lelièvre V., Becq-Giraudon L., and Meunier A.C. VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment. Mol. Neurobiol. 10 (1995) 115-134
46. Muller J.M., Philippe M., Chevrier L., Héraud C., Alleaume C., and Chadéneau C. The VIP-receptor system in neuroblastoma cells. Regul. Peptides 137 (2006) 34-41
47. Nakaso K., Ito S., and Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432 (2008) 146-150
48. Osen-Sand A., Catsicas M., Staple J.K., Jones K.A., Ayala G., Knowles J., Grenningloh G., and Catsicas S. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature 364 (1993) 445-448
49. Osen-Sand A., Staple J.K., Naldi E., Schiavo G., Rossetto O., Petitpierre S., Malgaroli A., Montecucco C., and Catsicas S. Common and distinct fusion proteins in axonal growth and transmitter release. J. Comp. Neurol. 367 (1996) 222-234
50. Oyler G.A., Higgins G.A., Hart R.A., Battenberg E., Billingsley M., Bloom F.E., and Wilson M.C. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J. Cell. Biol. 109 (1989) 3039-3052
51. Persson E., Voznesensky O.S., Huang Y.F., and Lerner U.H. Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts. Bone 37 (2005) 513-529
52. Puffer E.B., Lomneth R.B., Sarkar H.K., and Singh B.R. Differential roles of developmentally distinct SNAP-25 isoforms in the neurotransmitter release process. Biochemistry 40 (2001) 9374-9378
53. Qi X.L., Nordberg A., Xiu J., and Guan Z.Z. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease. Neurochem. Int. 51 (2007) 377-383
54. Redmond L., Oh S.R., Hicks C., Weinmaster G., and Ghosh A. Nuclear Notch1 signaling and the regulation of dendritic development. Nat. Neurosci. 3 (2000) 30-40
55. Ross R.A., and Biedler J.L. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res. 45 (1985) 1628-1632
56. Sanders J.D., Yang Y., and Liu Y. Differential turnover of syntaxin and SNAP-25 during synaptogenesis in cultured cerebellar granule neurons. J. Neurosci. Res. 53 (1998) 670-676
57. Schomerus C., Maronde E., Laedtke E., and Korf H.W. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence. Cell Tissue Res. 286 (1996) 305-313
58. Sherwood N.M., Krueckl S.L., and McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 21 (2000) 619-670
59. Shi X.Z., Choudhury B.K., Pasricha P.J., and Sarna S.K. A novel role of VIP in colonic motility function: induction of excitation-transcription coupling in smooth muscle cells. Gastroenterology 132 (2007) 1388-1400
60. Singh U.S., Pan J., Kao Y.L., Joshi S., Young K.L., and Baker K.M. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Biol. Chem. 278 (2003) 391-399
61. Smith R., Klein P., Koc-Schmitz Y., Waldvogel H.J., Faull R.L., Brundin P., Plomann M., and Li J.Y. Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. J. Neurochem. 103 (2007) 115-123
62. Takei N., Sasaoka K., Inoue K., Takahashi M., Endo Y., and Hatanaka H. Brain-derived neurotrophic factor increases the stimulation-evoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats. J. Neurochem. 68 (1997) 370-375
63. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354
64. Vaughan P.F., Peers C., and Walker J.H. The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. Gen. Pharmacol. 26 (1995) 1191-1201
65. Washbourne P., Thompson P.M., Carta M., Costa E.T., Mathews J.R., Lopez-Benditó G., Molnár Z., Becher M.W., Valenzuela C.F., Partridge L.D., and Wilson M.C. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat. Neurosci. 5 (2002) 19-26
66. Yoshida S., Narita T., Taga T., Ohta S., and Takeuchi Y. Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex. J. Neurosci. Res. 69 (2002) 642-652